Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new biomarkers may offer a more sensitive approach than existing standards for monitoring kidney health and can lead to more tolerable treatment options.
